药品名称AGGRENOX
申请号020884产品号001
活性成分ASPIRIN; DIPYRIDAMOLE市场状态处方药
剂型或给药途径CAPSULE, EXTENDED RELEASE;ORAL规格25MG;200MG
治疗等效代码AB参比药物
批准日期1999/11/22申请机构BOEHRINGER INGELHEIM PHARMACEUTICALS INC
化学类型New combination审评分类Priority review drug
与本品相关的专利信息(来自橙皮书Orange Book)
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
60155772017/01/18U-302PDF格式
历史专利信息
与本品相关的市场独占权保护信息
独占权代码失效日期
历史市场独占权保护信息
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
020884035APLabel2015/11/12下载
020884035APLetter2015/11/13下载
020884030APLetter2012/09/11下载
020884030APLabel2012/09/11下载
020884018APLetter2009/10/05下载
020884018APLabel2009/10/14下载
020884014APLabel2006/12/04下载
020884014APLetter2006/12/04下载
020884012APLetter2007/03/31下载
020884012APLabel2007/03/31下载
020884007APLetter2004/02/02下载
020884003APLetter2001/04/23下载
020884001APLabel2003/04/24下载
020884000APReview2003/04/30下载
020884000APLetter2003/04/30下载
020884000APLabel2003/04/30下载
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
020884035AP2015/11/09Labeling Revision
020884033AP2014/05/30Manufacturing Change or Addition
020884032AP2013/05/29Manufacturing Change or Addition
020884030AP2012/09/07Labeling Revision
020884018AP2009/10/01Efficacy Supplement with Clinical Data to Support
020884014AP2006/11/28Labeling Revision
020884012AP2007/03/26Efficacy Supplement with Clinical Data to Support
020884007AP2004/01/28Labeling Revision
020884006AP2002/06/20Control Supplement
020884005AP2002/02/08Manufacturing Change or Addition
020884004AP2001/09/21Control Supplement
020884003AP2001/04/23Package Change
020884002AP2000/10/17Manufacturing Change or Addition
020884001AP2001/08/10Labeling Revision
020884000AP1999/11/22Approval